INTRODUCTION
Epstein-Barr virus (EBV) is the best known member of the gamma-1 herpesviruses; B-lymphotropic agents with oncogenic potential found only in Old-and New-World primate hosts. These agents carry a large array of lytic-cycle genes, many with homologues in other herpesviruses, and a set of latent genes, unique to the genus lymphocryptovirus, whose expression leads to B-cell growth transformation (Rickinson & Kieff, 2007) . Genomic comparisons between contemporary viruses suggest that, as the ancestral lymphocryptovirus evolved within different primate hosts (Ehlers et al., 2010) , latent gene sequences have diversified most rapidly (Wang et al., 2001) . Even among EBV strains themselves, latent gene polymorphisms have the potential to distinguish between strains from different human populations and, more subtly, between individual strains circulating within any one population (Bhatia et al., 1996; Edwards et al., 1999; McGeoch & Gatherer, 2007; Sample et al., 1990) .
EBV isolates are broadly classifiable as either type 1 or type 2 based on linked type-specific polymorphisms at the EBNA2 and at the distant EBNA3A, 3B and 3C gene loci (Sample et al., 1990) ; inter-typic recombinants have been identified but are relatively rare (Midgley et al., 2000; Yao et al., 1996) . Type 1 strains appear to be dominant in most, if not all, human populations and clearly show much more intra-typic sequence diversification than type 2 strains at these loci (Rickinson & Kieff, 2007) . Thus studies, mainly on viruses from European and Chinese donors, have identified several different alleles of the type 1 EBNA2 (Midgley et al., 2003a; Schuster et al., 1996) and type 1 EBNA3A, 3B and 3C (Görzer et al., 2006; Midgley et al., 2003a) genes. The dominant alleles are different in the geographically distinct populations but, within each population, individual type 1 viruses tend to show strong linkage between their EBNA2 and EBNA3 alleles. There are also a number of defined alleles of EBNA1 (Bhatia et al., 1996) and of LMP1 (Edwards et al., 1999) ; these are not so strictly linked either to one another or to EBNA2/3 identity, but their prevalence is again clearly influenced by geography (Chang et al., 2009 ).
To what extent such latent gene diversification is stochastic and to what extent it is driven by the genetic background of the host population remains to be determined. The issue was brought into sharp focus by the finding that key HLArestricted T-cell epitopes were mutated in virus strains prevalent in the Chinese population Gavioli et al., 1993) , suggesting that pressure from the T-cell response had shaped the evolution of EBV in that population. However, such an interpretation remains in dispute (Burrows et al., 1996 (Burrows et al., , 2004 Khanna et al., 1997) , not least because of the paucity of data on virus isolates from other Asian populations with different HLA backgrounds. This emphasizes a more general problem, the extent to which the 'Asian' EBV signature is dominated by data from Chinese virus isolates, with little attention to geographical divergence within the Asian virus family. Here we turn to the identity of EBV strains in Japan, analysing latent gene sequences amplified from the peripheral blood mononuclear cells (PBMCs) of control donors and of patients with EBV-associated T/NK lymphoproliferative disease (T/NK-LPD) (Kawa, 2003; Ohshima et al., 2008) , a condition characterized by high viral loads following entry of EBV into the T-or NK-cell lineage (Kashiwagi et al., 2007; Kawa, 2003; Kikuta et al., 1988; Kimura, 2006; Ohshima et al., 2008) .
RESULTS
We selected six latent-cycle genes as markers of EBV strain identity, EBNAs 1, 2, 3A, 3B, 3C and LMP1, and amplified PBMC DNA from Japanese donors across intragenic regions that, in European and Chinese virus isolates (Bhatia et al., 1996; Chang et al., 2009; Edwards et al., 1999; Sample et al., 1990) , contain informative polymorphisms (see Fig. 1a ). Consistent with their diagnosis, all 21 T/NK-LPD patients showed high viral loads by quantitative PCR (Q-PCR) across a non-polymorphic region of the genome (range 1.1610 4 -7.6610 6 genomes per 10 6 PBMCs) and gave amplifiable products at all the latent gene loci. Viral loads were much lower in the control donors (range 0-2.2610 5 genomes per 10 6 PBMCs) but 10 of 21 individuals with higher loads also gave amplifiable products at all loci. We therefore report the results obtained from 31 individuals (21 patients and 10 controls) with complete datasets.
EBNA1, LMP1 and EBNA2 loci
The four main allelic variants of the EBNA1 sequence, known from earlier work (Bhatia et al., 1996) , differ by up to 20 codon changes from the prototype B95.8 strain but are named after signature changes at codon 487. The A 487 (B95.8) and T 487 alleles are common among European isolates, the T 487 and L 487 alleles are common in Africa and the V 487 allele are common in China (Bhatia et al., 1996; Habeshaw et al., 1999; Sandvej et al., 2000) . Fig. 1(b) shows the nucleotide and, where appropriate, amino acid changes that distinguish the different reference alleles from the B95.8 sequence in the amplified region (codons and summarizes the allele distribution observed among Japanese strains. All but one of these strains had a classical V 487 allelic sequence, the exception being one virus with an L 487 allele. The prevalent EBV stains in Japan therefore carry an EBNA1 allele like that seen in Chinese populations.
We next examined allelic identity at the LMP1 locus, where the reference panel included the common Chinese allele, Ch1, which has several sequence changes and a 30 bp deletion (codons 34-352) relative to B95.8 (Chang et al., 2009 ). Other reference alleles show different sets of changes relative to B95.8 and either have the 30 bp deletion (Med1) or do not have the deletion (Ch2 and Med2); note that Med1 and Med2 were originally called Med+ and Med2, respectively (Edwards et al., 1999; Miller et al., 1994) . Initially we used a heteroduplex tracking assay (Sitki-Green et al., 2002) in which a polymorphic region of LMP1 straddling the deletion is amplified using conserved-site primers and then the allele-specific product is identified by its distinct mobility in an electrophoresis gel after heteroduplex formation with a common probe. As illustrated in Fig. 2(a) , many Japanese strains gave products running at or very close to the position of the Ch1 reference allele and distinct from that of the other reference alleles. Fig. 2(b) summarizes the results of sequencing the Japanese viruses (and the reference alleles) across this same region, again all changes are shown relative to B95.8. The great majority of Japanese strains (28 of 31) carried Ch1-based sequences with some intra-allelic variation, just as were observed for Chinese viruses (Edwards et al., 1999; Miller et al., 1994) . Thus, three suballeles, Ch1 (E, G) , Ch1 (E, D) and Ch1 (Q, G) , could be identified based on amino acid identities at positions 326 and 335, with some viruses (see Fig. 2 legend) showing one or two further nucleotide changes that were idiosyncratic, i.e. unique to an individual virus strain.
At the EBNA2 locus, initial screening with type-specific primer-probe combinations (data not shown) revealed that all 31 Japanese strains carried a type 1 sequence, in line with an earlier report (Xu et al., 2000) . Among the best known type 1 EBNA2 alleles, 1.1a and 1.3b are common among European virus strains, with 1.2 and 1.3a also present (Schuster et al., 1996) . By contrast, two other alleles, 1.1b/Wu and 1.3e/Li (combined nomenclatures from Schuster et al., 1996 and Midgley et al., 2003a) are dominant in Chinese virus strains. Initial screening in an EBNA2 heteroduplex tracking assay (Tierney et al., 2006) showed, as in Fig. 3(a) , that Japanese virus strains yielded products that ran close to the 1.1a (B.95.8) reference. Subsequent sequence analysis, summarized in Fig. 3(b) , confirmed the marked homogeneity among Japanese viruses at this locus; all followed the 1.1b/Wu allelic sequence, with only two examples of additional idiosyncratic changes (see Fig. 3 legends) , one virus having a synonymous nucleotide change and another three nonsynonymous changes.
EBNA3A, 3B and 3C loci
The fact that, in European and Chinese virus isolates, EBNA2 and EBNA3A/B/C allelic identities appear to be strongly linked (Görzer et al., 2006; Midgley et al., 2003a; Sample et al., 1990) led us to ask whether the observed homogeneity among Japanese strains at EBNA2 would be replicated at the EBNA3 loci. The results are summarized in Fig. 4 , in each case showing the data from Japanese samples against typical reference strains from China. Note that there are two main families of EBNA3A, 3B and 3C allelic sequences in the Chinese isolates which have been called Wu and Li because they tend to occur in linkage with, respectively, the 1.1b/Wu and 1.3e/Li alleles at the EBNA2 locus. In addition, there is a third family of Chinese EBNA3A, 3B and 3C alleles that occurs less frequently, which can be in linkage with either EBNA2 allele, and which we termed 'Sp' (Midgley et al., 2003a) .
In contrast to the situation at EBNA2, Japanese virus strains were found to be heterogeneous at all three EBNA3 loci. Furthermore, at each locus, the different Japanese alleles were clearly recognizable as relatives of the above Wu, Li or Sp sequences. Thus at EBNA3A (Fig. 4a) , there was a roughly equal split between Wu-related sequences (the two suballeles Wu9 and Wu0 are distinguished from the Wu consensus by changes at, respectively, codon 317 and codons 246 and 317) and Li-related sequences (the two suballeles Li9 and Li0 are distinguished from the Li consensus by changes at, respectively, codon 317 and codons 198 and 317). By contrast, at EBNA3B (Fig. 4b) there was a roughly equal split between Li-related sequences (two suballeles Li9 and Li0 distinguished from the Li consensus by changes at, respectively, codons 391 and 417, and codons 402 and 424) and an Sp-related sequence (suballele Sp9 distinguished from the Sp consensus by changes at codons 399 and 466). Only one Japanese strain had a Wurelated EBNA3B sequence (suballele Wu9, distinguished from the Wu consensus by a change at codon 400). At EBNA3C (Fig. 4c) , there was again a roughly equal split between viruses with Li and with Sp alleles, in this case all sequences being identical to the relevant Chinese consensus sequence.
Allelotyping and EBV strain identification
One potential complication in attempting to infer EBV strain identity from sequences at distinct genomic loci is the fact that virus carriers, even healthy individuals, may harbour more than one EBV strain (Sitki-Green et al., 2003) . Because such co-infections can typically be detected both by heteroduplex-tracking assays and by allelic sequencing (Sitki-Green et al., 2002; Tierney et al., 2006) we used both techniques in the present work. Importantly, within each individual, we only ever detected one sequence per genomic locus. We therefore infer that, for each donor studied, the allelic sequences at each of the six loci are derived from the same resident virus strain.
On this basis, Fig. 5 shows the complete EBNA1, LMP1, EBNA2 and EBNA3A, 3B and 3C allelotype of the 31 Japanese virus strains, subdividing these into two groups based on allelic identity at the EBNA3 gene loci. Note that . Japanese strains were similar in this respect and some also showed a change at codon 326 (gag, E to cag, Q); hence, Japanese Ch1 alleles were subdivided into Ch1 (E, G) , Ch1 (E, D) and Ch1 (Q, G) based on the identity of amino acids (326, 335) . Note that additional idiosyncratic changes (not shown) were also observed in 11 patients (P2, S366A; P6, G354V; P7, G370A; P9, D373N; P10, P320* (silent change), G355A, H358Q; P15, G331R; P16 and P17 D333E; P19, B95.8-like at 338; P20 and P21,V327I) and in three control donors (C1, Q322H; C2, L323S; and C4, D333H).
Latent gene markers of EBV strain identity
we have pooled the control (C) donor-derived and T/NK-LPD patient (P)-derived strains in this analysis since they were similarly distributed between allelotypes. The upper group have entirely Li-related alleles throughout the EBNA3A, 3B and 3C loci, while the lower group are almost all recombinants of Wu-related sequences at EBNA3A and Sp-related sequences at the EBNA3B and 3C loci. This emphasizes the strong genetic linkage between these adjacent loci in the virus genome and the relative rarity of recombination between the Li-related and Wu/Sprelated allelotypes. Interestingly, while this linkage does not extend to include polymorphism at the EBNA2 locus, Japanese viruses do display another less obvious trend noted in earlier work with both European (Görzer et al., 2006; Sample et al., 1990) and Chinese (Midgley et al., 2003a) strains, whereby allelic identities at the EBNA3 and LMP1 loci are frequently linked. Thus 9 of 10 viruses with the common Li9/Li9/Li allele combination at EBNA3A/B/C had a Ch1 (E, D) allele at LMP1; conversely 11 of 15 viruses with a common Wu9/Sp9/Sp EBNA3 combination had a Ch1 (Q, G) allele at LMP1. Furthermore, of the six viruses with the less common EBNA3 allelotypes (P1, P2 and C1 in Fig. 3 . Analysis of EBNA2-sequence variation in Japanese T/NK-LPD and control donor strains. (a) EBNA2 heteroduplex tracking assay showing six representative T/NK LPD strains. The amplified EBNA2 PCR product from these isolates was hybridized to a radiolabelled type 1.1a probe and subjected to acrylamide gel electrophoresis alongside reference samples carrying the 1.1a (B95.8), 1.2, 1.3a, 1.3b and 1.3e alleles. Note that the 1.3a, b and e alleles contain a CTC 3 bp insertion compared with the 1.1a and 1.2 strains, hence their heteroduplexes are more severely retarded in the gel. (b) Sequence analysis of EBNA2 codons 160-225 in patient and control donor stains. Sequence changes are shown relative to the B95.8 prototype 1.1a EBNA2 allele as in Fig. 1(b) ; corresponding changes are shown for reference strains carrying 1.1b/Wu, 1.2, 1.3a, 1.3b and 1.3e/Li EBNA2 alleles. Note that additional idiosyncratic changes (not shown) were also detected in one patient (P17, P324*) and one control donor (C1: H268Q, P271H and P274L).
the Li-based group; P11, P12 and P10 in the Wu/Sp-based group), five had less common LMP1 alleles (Ch1 (E, G) or Ch2). Such observations are consistent with the coexistence of different families of EBV isolates, with distinct evolutionary histories, within the Japanese population.
Allelotyping of EBV strains pre-and posthaemopoietic stem cell transplant One of our objectives in this work was to establish a series of assays that could be used to track the identity of EBV strains in Japanese patients, including T/NK-LPD patients, before and after transplantation (Kawa et al., 2007) . In such circumstances, an existing EBV infection may be cleared and a new strain acquired, or a new strain acquired alongside the original strain (Gratama et al., 1988; Kawa et al., 2007) . Table 1 summarizes the results of five patients who developed EBV-positive disease post-transplant, either conventional lymphoproliferative disease (LPD) of B-cell origin (B-LPD), a relapse of T/NK-LPD or both. Two had a very rapid course of disease post-transplant. Patient BS1 originally presented with Blau syndrome, required a transplant and went on to develop B-LPD 1 month later. Patient P4 had T/NK-LPD, was transplanted and relapsed with T/NK-LPD also 1 month later. In both cases the resident EBV strain pre-transplant and that associated with disease post-transplant had the same allelotype at all six latent gene loci. It is therefore very likely (particularly in view of the rapidity of disease post-transplant) that in both cases the post-transplant lesions carried the pre-transplant virus; this could reflect either the persistence of that strain throughout the transplant period or, possibly, the reacquisition of the same strain from a close contact. Either way, allele sequencing of this kind cannot definitively prove identity for the pre-and post-transplant strains because both patients carried a virus with a relatively common Japanese allelotype (EBNA1 V 487 ; EBNA2 1.1b/Wu; LMP1 Ch1 (E, D) ; EBNA3A/ B/C Li0/Li0/Li with no idiosyncratic changes).
By way of contrast, another patient, HB1, who was transplanted for hepatoblastoma and developed B-LPD 7 months later, provided a clear case where the posttransplant disease involved a newly acquired virus strain. Thus, only a type 2 virus (based on EBNA3C allele typing) was ever detectable in pre-transplant bleeds. Following transplant, the patient became negative for IgG antibodies to virus capsid antigen, consistent with clearance of the initial EBV carrier state, and the subsequent B-LPD lesion carried a type 1 strain with a distinctive Japanese allelotype.
We were particularly interested in two patients who developed both T/NK-LPD and B-LPD at different points in their history. Patient P17 presented with T/NK-LPD, was transplanted and developed B-LPD 6 months later. We identified a virus with the same allelotype in both lesions (EBNA1 V487 ; LMP1 Ch1 (Q, G) ; EBNA2 1.1b/Wu; EBNA3A/ B/C Wu9/Sp9/Sp). Once again this is a relatively common Japanese allelotype, but in this case we could say with near certainty that both diseases involved the same virus strain since this particular virus had an idiosyncratic change in both its EBNA2 and its LMP1 allelic sequence (see legends of Figs 2 and 3). Finally patient P1 presented with T/NK-LPD, was transplanted and 8 months later developed B-LPD, was treated and after a further 14 months again presented with T/NK-LPD. We analysed the resident viral strain in all three LPD lesions and on each occasion found a virus with an allelotype (EBNA1 V487 ; LMP1 Ch1 (E, G) ; EBNA2 1.1b/Wu; EBNA3A/B/C Li9/Li9/Li) that was unique among the 31 Japanese virus strains found in the present study. Again, therefore, it is very likely that the same virus was driving lymphoproliferative diseases of T/NK-cell and of B-cell origin in this patient.
DISCUSSION
Here we have studied latent gene polymorphisms among Japanese virus strains, in order to counterbalance the large volume of data from Chinese viruses that currently define the Asian EBV signature. The results shed interesting light on the distinct evolutionary paths of EBV in these different host populations. Clearly Japanese viruses do belong to the Asian family, most carrying the same alleles as Chinese strains at the EBNA1 (V 487 ) and LMP1 (Ch1) loci, as others have also reported (Chen et al., 1998; Oshima et al., 1999; Xu et al., 2000) . We find that both sets of viruses also carry Asian alleles at the EBNA2 and EBNA3A/B/C loci, but here interesting differences emerge. Earlier work (Midgley et al., 2003a) showed that most Chinese viruses fall into one of two family groups based on a linked EBNA2 and EBNA3A/ B/C allelotype, with 'Wu family' strains having Wu sequences and 'Li family' strains having Li sequences at all four loci. Occasionally, in both Wu and Li family viruses, one or more of the EBNA3 loci contained a sequence with its own characteristic pattern of changes, thereby identifying third alleles of EBNA3A, 3B and 3C, which in each case were called 'Sp' due to their sporadic appearance. Here we show, in contrast, that all Japanese viruses are clearly 'Wu family' at the EBNA2 locus, as defined by the presence of the Chinese consensus 1.1b/Wu allelic sequence. However, they do segregate sharply into groups at the EBNA3A/B/C loci. One group has Li-related alleles (designated Li9 and Li0) at both EBNA3A and 3B, and the Chinese consensus Li allele at EBNA3C. The other group has Wu-related alleles (Wu9 and Wu0) at EBNA3A, an Sp-related (Sp9) or rarely a Wu-related sequence (Wu9) at EBNA 3B, and the Chinese consensus Sp sequence at EBNA3C.
We draw the following general conclusions from these findings: (i) while the adjacent EBNA3A/3B/3C loci have co-evolved as linked alleles, linkage with the distant EBNA2 locus (so apparent in Chinese viruses) is not typical of all Asian strains, (ii) the EBNA3A and 3B loci have undergone greater diversification than the EBNA3C locus, in terms of both of the number of sequence changes in Asian alleles versus the Caucasian (B95.8) prototype and of the number of suballelic variants seen at each locus, and (iii) the dominance of Sp-related alleles at the EBNA3B and 3C loci in Japanese virus strains contrasts with their relative rarity in Chinese viruses, forcing a reappraisal of the overall contribution of Sp sequences to Asian virus evolution. This work therefore provides a first insight into the relationships between virus strains circulating within different Asian populations. However, we would stress that our findings are based on sequence analysis from selected regions of a subset of latent genes and must be interpreted in that light. The full complexity of current EBV strain diversity will only be revealed once we have complete genome sequence data on multiple isolates from different locations. An analysis on that scale represents an important long-term goal.
Interestingly, the present data are directly relevant to a specific question that was raised during our earlier work on Chinese viruses, namely to what extent the evolution of EBV within that population has been shaped by host genetics. Thus EBV strains prevalent in the Chinese population, where an unusually high proportion of people (around 55 %) carry the HLA-A11 allele, show marked sequence diversification in a region of EBNA3B encoding the two epitopes (9-mer and 10-mer peptide sequences abbreviated to IVT and AVF, respectively) which, in HLA-A11-positive Caucasians, dominate the latent antigenspecific CD8
+ T-cell response Gavioli et al., 1993; Midgley et al., 2003b) . Whether epitope-loss viruses have reached high prevalence in the Chinese population by chance or as a result of immune selection remains the subject of debate (Burrows et al., 1996 (Burrows et al., , 2004 Khanna et al., 1997) . This impasse reflects the fact that so little is known about epitope status in virus strains from other populations in the Asian region. There are data from isolated population groups in New Guinea (Burrows et al., 1996; de Campos-Lima et al., 1993) but they are difficult to interpret because New Guinea viruses lie outside the typically Asian lineage (Burrows et al., 2004; Khanna et al., 1997) .
Here we show that in Japan (where the frequency of HLA-A11 is only 16 %), the EBNA3 alleles clearly share a common evolutionary origin with Chinese EBNA3 alleles, yet epitope loss in Japanese strains is relatively rare. Thus, looking at the IVT (EBNA3B 416-424) and AVF (EBNA3B 399-408) epitope regions as marked in Fig.  4(b) , the most frequent Li-related allele in Japan, Li0, and the most frequent Sp-related allele, Sp9, have no epitopeloss mutations in either epitope (i.e. they have the B95.8 sequence throughout). This is in stark contrast to the corresponding Chinese alleles, Li and Sp, respectively, both of which had mutations in both epitopes. Among Japanese strains, only the two rarer EBNA3B alleles, Li9 and Wu9, had epitope mutations. Therefore, as summarized in Table 2 , only 3 of 31 Japanese virus strains showed evidence of A11 epitope mutation, whereas Chinese virus isolates (established in earlier work, Midgley et al., 2003a) were very frequently mutated, with a range of different and control donor strains. Sequence changes are shown relative to the prototype B95.8 strain as in Fig. 1(b) ; corresponding changes are shown for reference Chinese virus strains carrying the Li, Wu and Sp EBNA3A alleles. Japanese EBNA3A alleles were classified as Li-related (designated Li9 or Li99 based on divergence from the Li consensus at codon 317 or codons 198 and 317, respectively), or Wu-related (designated Wu9 or Wu99 based on divergence from the Wu consensus at codon 317 or codons 246 and 317, respectively). Note that one additional idiosyncratic change (not illustrated) was found in one control donor (C1, G201R). (b) Sequence analysis of EBNA3B codons 315-466 in patient and control donors. Sequence changes are shown relative to the prototype B95.8 strain as in Fig. 1(b) ; corresponding changes are shown for reference Chinese virus strains carrying the Li, Wu and Sp EBNA3B alleles. Japanese EBNA3B alleles were classified as Li-related (designated Li9 or Li99 based on divergence from the Li consensus at codons 391, 402 and 424 or 402 and 424, respectively), or Wu-related (designated Wu9 based on divergence from the Wu consensus at codon 400), or Sprelated (designated Sp9 based on divergence from the Sp consensus at codons 399, 417 and 466). Sequence changes which affect the A11-restricted AVF and IVT T-cell epitopes are highlighted by boxes. Note that additional idiosyncratic changes (not shown) were found in four patients (P3, P458*; P8, T459M; P9, F420L; and P10, V452*).
(c) Sequence analysis of EBNA3C codons 134-275 in patient and control donors. Sequence changes are shown relative to the prototype B95.8 strain as in Fig. 1(b) ; corresponding changes are shown for reference Chinese virus strains carrying the Li, Wu and Sp EBNA3C alleles. At this locus, all Japanese strains could be classified as carrying either consensus Li or Sp sequences. Note that additional idiosyncratic changes (not shown) were found in two patients (P10,V246 B95.8-like; and P21, R198G) and one control donor (C2, F144C).
Latent gene markers of EBV strain identity sequence changes evident in different isolates. Note that two earlier studies of Japanese EBV strains, amplifying just across the IVT/AVF epitope region and using fresh or archived biopsy tissues, have also reported low frequencies of sequence change, affecting one or other epitope in 20-25 % of samples studied (Chu et al., 1999; Kanno et al., 2000) . Thus, the predominance of A11 epitope-loss mutants appears to be a specific feature of contemporary Chinese virus strains and not a general feature of Asian virus isolates. This is at least consistent with the concept of immune selection having influenced EBV evolution in the founder Chinese population. However a more definitive test of the hypothesis is needed, and this depends upon finding a parallel set of circumstances to those seen in China, i.e. where a host population has an unusually high frequency of an HLA allele that normally acts as a dominant restriction element for EBV-specific Tcell responses. In this regard HLA-A24.02 is unusually prevalent in the Japanese population (Furutsuki et al., 2004) but, unfortunately, happens to be a generally weak response allele for EBV with just a few subdominant epitopes defined (Hislop et al., 2007; Woodberry et al., 2005) . Interestingly, the best known of these epitopes lies in EBNA3A (amino acids 246-253 of the B85.8 strain sequence; Burrows et al., 1994) and, with reference to Fig.  4(a) , shows that, perhaps predictably, this epitope sequence is retained in its antigenic form in all but a small minority of Japanese strains.
Finally, we show how knowledge of latent gene polymorphisms can also be put to more immediate practical use, as a means of distinguishing between the many individual virus strains prevalent within a host population. This can be important in clinical situations where one wants to track the source of disease-related strains, for example in HSCT recipients at risk of EBV-associated disease post-transplant (Kawa et al., 2007) . As illustrated in Table 1 , this allowed us to identify one patient (BS1) in whom a B-LPD arising post-transplant most probably carried the patient's pre-existing virus strain and another patient (HB1) where it clearly involved a newly acquired strain. Most interestingly, it also provided two examples of patients where, as far as we can determine, the same virus strain was identified in T/NK-LPD pre-transplant and in B-LPD post-transplant. In one case (P1) the virus could be identified through having a rare allelotype, in another (P17) through having a relatively common allelotype but with an additional idiosyncratic change in each of two loci. This is the first clear evidence that a single virus strain can cause lymphoproliferative disease of T/NK-cell origin and of Bcell origin in the one patient. As such, it illustrates how a detailed knowledge of EBV polymorphism is not just of interest to students of virus evolution but can also help to define the pathogenic potential of individual virus strains.
METHODS
Samples. PBMCs were isolated from 21 Japanese control donors (healthy volunteers or patients with non-EBV-related conditions) and 21 patients presenting with T/NK-LPD. Pre-and post-transplant samples were obtained from three T/NK-LPD patients (P1, P4 and P17) who, following HSCT, either re-presented with EBV-positive T/ NK-LPD or developed conventional EBV-positive post-transplant B-LPD, and from two other patients (BS1 and HB1, initially presenting with Blau syndrome and hepatoblastoma, respectively), who developed B-LPD post-HSCT. All volunteer donors and all patients or their guardians gave informed consent.
EBV genome load. Total EBV genome load in PBMCs was, in each case, determined by a Q-PCR assay across the non-polymorphic EBV pol gene sequence as described (Junying et al., 2003) .
EBNA2 and LMP1 heteroduplex-tracking assay (HTA). DNA was extracted from the PBMCs of patient and control samples and EBNA2 and LMP1 HTA analysis was carried out as described previously (Sitki-Green et al., 2002; Tierney et al., 2006) . Briefly EBNA2 DNA was amplified by using two rounds of PCR, firstly with the common 
*Distribution of epitope changes in the 25 Chinese LCL-derived isolates studied in the present work. DDistribution of epitope changes in the 31 Japanese EBV strains studied in the present work. One strain (P10) had mutations in both epitopes, two strains (P1 and P2) had mutations in the IVT epitope only. Latent gene markers of EBV strain identity E2C and E2Seq4 primers, then in a nested reaction with either the type 1-specific E2SEQ-7.1 and -8.1 primers or the type 2-specific E2SEQ-7.2 and -8.2 primers. The PCR products were denatured and hybridized to type 1 or type 2 EBNA2-specific radiolabelled probes. LMP1 DNA was also amplified by using two rounds of PCR, firstly with LMP-3UT and Fuc-HindIII primers and a secondly with FucHindIII and FUE-Eco primers (Sitki-Green et al., 2002 ). The PCR products were then hybridized to a Med1 (Med+) probe (SitkiGreen et al., 2002; Tierney et al., 2006) . The EBNA2 and LMP heteroduplexes were then subjected to electrophoresis through 8 or 6 % polyacrylamide gels, respectively. The gels were then dried and exposed to film. For each gel, reference controls corresponding to each of the known EBNA2 or LMP1 strains were loaded alongside the samples. Note that herein the LMP1 alleles originally called Med+ and Med2 are referred to as Med1 and Med2, respectively (Edwards et al., 1999) .
Sequencing of EBV latent genes. The codons sequenced within each gene are shown in Fig. 1(a) . The DNA fragments were amplified by using nested PCRs that were agarose-gel purified and directly sequenced using a BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems) with the same primers that were used for amplification. EBNA1 amplification and sequencing was carried out as previously described (Midgley et al., 2000) . EBNA2 and LMP1 sequencing was carried out by using the same PCR products used for HTA. EBNA3A was amplified firstly with A1F and A4R primers and subsequently with primers A2F and A4R. EBNA3B was amplified with primers E3B8.2 and E3B9.2, followed by primers E3B8 and E3B9. EBNA3C was amplified with primers C2F and C4R followed by primers C2F and C2R (Midgley et al., 2003a ). An additional internal primer, A3.2F (59-ACACTTGGGTGCACAGGTGGCC-39; B95.8 coordinates 92 925-92 946), was used to sequence EBNA3A.
